Sutro Biopharma STRO
NASDAQ STRO
$16.10 +0.07 (+0.44%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sutro Biopharma (STRO) EV to CFO (2018 - 2022)

Updated

Sutro Biopharma's EV to CFO came in at 45.72 for Q4 2022.

Analysis

Sutro Biopharma (STRO) EV to CFO (2018 - 2022) Analysis & Trends

Going back to Q3 2018, Sutro Biopharma's EV to CFO data covers 6 quarters.

  • Going back by year, EV to CFO was -12.03 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Sutro Biopharma 265.72 Mn -412.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 45.72
Sep 30, 2022 2.72
Jun 30, 2019 18.29
Mar 31, 2019 12.00
Dec 31, 2018 -12.03
Sep 30, 2018 -8.40
API Access

Sutro Biopharma EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=STRO&period=max&api_key=YOUR_API_KEY